A drugmaker has agreed to pay $15.4 million to settle claims that a company it bought had it lavished doctors with dinners and entertainment to encourage them to keep prescribing a drug as its price ballooned.
Under an agreement announced Wednesday by the U.S. Department of Justice, Britain-based Mallinckrodt resolved kickback claims that were spelled out in a court filing earlier this year. The claims pertain to actions from 2009 to 2013 by Questcor Pharmaceuticals, a company Mallinckrodt has since purchased.
The government says the company raised the price of a roughly 5-dose vial of Acthar, used to treat conditions related to multiple sclerosis, lupus and other diseases, from $50 to $32,000 from 2001 through 2014.
In a statement, the company said it is glad to have the issue resolved.